Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Anti-proliferative activity and mechanism of action of titanocene dichlorideCHRISTODOULOU, C. V ; ELIOPOULOS, A. G ; YOUNG, L. S ; HODGKINS, L ; FERRY, D. R ; KERR, D. JBritish journal of cancer, 1998-06, Vol.77 (12), p.2088-2097 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
2 |
Material Type: Artigo
|
Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell linesSHARP, S. Y ; SMITH, V ; HOBBS, S ; KELLAND, L. RBritish journal of cancer, 1998-07, Vol.78 (2), p.175-180 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
3 |
Material Type: Artigo
|
Establishment of a retinoic acid-resistant human acute promyelocytic leukaemia (APL) model in human granulocyte-macrophage colony-stimulating factor (hGM-CSF) transgenic severe combined immunodeficiency (SCID) miceFUKUCHI, Y ; KIZAKI, M ; IKEDA, Y ; KINJO, K ; AWAYA, N ; MUTO, A ; ITO, M ; KAWAI, Y ; UMEZAWA, A ; HATA, J ; UEYAMA, YBritish journal of cancer, 1998-10, Vol.78 (7), p.878-884 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
4 |
Material Type: Artigo
|
Association between tissue hypoxia and elevated non-protein sulphydryl concentrations in human cervical carcinoma xenograftsMORENO-MERLO, F ; NICKLEE, T ; HEDLEY, D. WBritish Journal of Cancer, 1999-11, Vol.81 (6), p.989-993 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
5 |
Material Type: Artigo
|
Application of an original RT-PCR-ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patientsFERRERO, J. M ; ETIENNE, M. C ; MILANO, G ; FORMENTO, J. L ; FRANCOUAL, M ; ROSTAGNO, P ; PEYROTTES, I ; ETTORE, F ; TEISSIER, E ; LEBLANC-TALENT, P ; NAMER, MBritish journal of cancer, 2000-01, Vol.82 (1), p.171-177 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
6 |
Material Type: Artigo
|
Development and characterization of a tamoxifen-resistant breast carcinoma xenograftNAUNDORF, H ; BECKER, M ; LYKKESFELDT, A. E ; ELBE, B ; NEUMANN, C ; BÜTTNER, B ; FICHTNER, IBritish journal of cancer, 2000-06, Vol.82 (11), p.1844-1850 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
7 |
Material Type: Artigo
|
Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour responseCAMERON, D. A ; GREGORY, W. M ; BOWMAN, A ; ANDERSON, E. D. C ; LEVACK, P ; FOROUHL, P ; LEONARD, R. C. FBritish journal of cancer, 2000-07, Vol.83 (1), p.98-103 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
8 |
Material Type: Artigo
|
Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell linesTONETTI, D. A ; CHISAMORE, M. J ; GRDINA, W ; SCHURZ, H ; JORDAN, V. CBritish journal of cancer, 2000-09, Vol.83 (6), p.782-791 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
9 |
Material Type: Artigo
|
Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell lineAPPIERTO, V ; CAVADINI, E ; PERGOLIZZI, R ; CLERIS, L ; LOTAN, R ; CANEVARI, S ; FORMELLI, FBritish journal of cancer, 2001-06, Vol.84 (11), p.1528-1534 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
10 |
Material Type: Artigo
|
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2SCHUYER, M ; VAN DER BURG, M. E. L ; HENZEN-LOGMANS, S. C ; FLERET, J. H ; KLIJN, J. G. M ; LOOK, M. P ; FOEKENS, J. A ; STOTER, G ; BERNS, EmjjBritish journal of cancer, 2001-11, Vol.85 (9), p.1359-1367 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |